193P - Impact of adjuvant trastuzumab emtansine (T-DM1) on incidence of metastatic breast cancer (mBC): An epidemiological model of patients with HER2-positive breast cancer (BC) who did not achieve pathological complete response (pCR) after neoadjuvant treatment (non-pCR)
| Autor: | Williamson, M.Y., Tomar, A., Jhuti, G.S., Revil, C., Kotzeva, A., Gururaj, K. |
|---|---|
| Zdroj: | In Annals of Oncology October 2019 30 Supplement 5:v65-v65 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|